Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C [Phase 4]
Phase 4 clinical trial update reporting sustained virological response to antiviral therapy in liver transplant recipients with recurrent he…
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity [Phase 4]
A Phase 4 trial assessing pegylated interferon plus ribavirin in subjects of First Nations, Metis, and Caucasian ethnicity for chronic hepat…
-
CLINICAL_TRIALS withdrawal · 2014-05-14Clinical Trial Update: Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a combination of Vitamin D, telaprevir, peginterferon, and ribavirin for Hepatitis C genotype 1 …
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382 [Phase 1]
A Phase 1 study in patients with chronic hepatitis C infection evaluating safety, tolerability, pharmacokinetics and antiviral activity of J…
-
CLINICAL_TRIALS withdrawal · 2014-05-09Clinical Trial Update: Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C [Phase 2]
Phase 2b trial of BMS-986094 and daclatasvir for chronic hepatitis C has been withdrawn, with or without ribavirin.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection [Phase 3]
Phase 3 trial evaluating a 12-week combination regimen of sofosbuvir with peginterferon alfa-2a and ribavirin in treatment-naive patients wi…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers [Phase 1]
This Phase I pharmacokinetic study evaluated TMC435 in healthy Chinese volunteers and has completed, describing how the drug behaves in the …
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection [Phase 1]
Phase 1 clinical trial update examining the interaction between alcohol and Highly Active Antiretroviral Therapy (HAART) in people with HIV …
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic interaction study in healthy subjects to evaluate how BMS-791325 affects midazolam exposure.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) [Phase 3]
Phase 3 trial results update for sofosbuvir plus ribavirin given for 12 or 16 weeks in treatment-experienced patients with chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C [Phase 2]
A Phase 2 study comparing continuous infusion of interferon to standard of care for chronic hepatitis C has completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: An Efficacy, Safety and Tolerability Study of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy [Phase 3]
Phase 3 study evaluating the efficacy, safety and tolerability of TMC435 (simeprevir) in genotype 1 hepatitis C patients who relapsed after …
-
CLINICAL_TRIALS research · 2014-04-23Clinical Trial Update: The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
This clinical trial update examines the natural history and treatment approaches for acute hepatitis C in individuals co-infected with HIV.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients [Phase 2]
This Phase 2 trial assessed the effectiveness, safety, and pharmacokinetics of TMC435 with peginterferon alfa-2a and ribavirin in chronic he…
-
CLINICAL_TRIALS withdrawal · 2014-04-17Clinical Trial Update: Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump [Phase 1, Phase 2]
A phase 1/2 trial evaluating sustained interferon alfa-2b therapy delivered via the InfraDure Biopump for relapsing Hepatitis C has been wit…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Hepatitis C in Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial update addressing chronic hepatitis C infection in renal transplant recipients; the snippet provides no status or res…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection [Phase 1]
Phase 1 trial update showing safety, tolerability, and pharmacokinetics of escalating doses of VCH 916 in subjects with hepatitis C.
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs) [NA]
A completed clinical trial assessing the impact of motivational interviewing on risky injecting behaviors among injecting drug users, with p…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Phase 3 Study of Sofosbuvir and Ribavirin [Phase 3]
A Phase 3 study evaluating the combination of Sofosbuvir and Ribavirin for Hepatitis C has completed. Results were posted in April 2014.
-
CLINICAL_TRIALS withdrawal · 2014-04-01Clinical Trial Update: Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
A clinical trial evaluating cellular immune responses in the liver of patients with chronic hepatitis C has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection [Phase 1, Phase 2]
A clinical trial update describing pharmacokinetics results from multiple ascending doses of VCH-222 in subjects with chronic hepatitis C (P…
-
CLINICAL_TRIALS research · 2014-03-10Clinical Trial Update: Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Clinical trial update examining innate immunity in HIV-positive patients co-infected with hepatitis B or hepatitis C. The trial status is cu…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) [Phase 2]
A Phase 2 trial completed evaluating the safety of two medications for treating hepatitis C in people with thalassemia.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Virology Follow up Study in Subjects Previously Treated With Telaprevir
A completed clinical trial update reporting virology follow-up results in hepatitis C patients previously treated with telaprevir.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Ribavirin Dose Optimization for the Treatment of Hepatitis C [Phase 2]
A Phase 2 clinical trial update reporting ribavirin dose optimization for chronic hepatitis C; the study is completed.